CNSP

CNS Pharmaceuticals, Inc.

Contracts

Total Value

Stock Metrics

0.8%

Short % Float

1.2d to cover · Low squeeze

12.5%

Inst % Float

10 holders · 2026-06-30

Stonepine Capital

Top Holder

4.2% of float

1.5M sh

Public Float

75/100

Dilution Score

High

2 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

75/100

HIGH

Inst: 12.47% · Top: Stonepine Capital Management, LLC

Biotech Analytics

Biotech / Pharma

19.27

Dilution Risk: HIGHBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk75

Clinical Trials12

Short Interest10